探究水胶敷料对奥沙利铂致静脉炎的预防效果，以降低静脉炎的发生率。

对中国医科大学附属第一医院2015年1月至2016年3月76例首次化疗行XELOX方案即静脉输注奥沙利铂和口服卡培他滨片的结肠癌患者，随机分为观察组和对照组，观察组采用水胶敷料在穿刺点上方沿血管走行外敷，对照组常规处理，比较两组静脉炎发生率。

观察组静脉炎发生率10.5%，对照组静脉炎发生率31.6%，两组比较差异有统计学意义（χ²=5.067，P<0.05）。

水胶敷料可以有效预防奥沙利铂致静脉炎，很好的保护患者的外周静脉，且操作简单，患者感觉舒适，也能减少不必要的人力物力，值得临床推广。

To investigate the effects of hydrocolloid dressing on phlebitis prevention caused by Oxaliplatin.

From January 2015 to March 2016, seventy-six colon cancer patients treated with XELOX regimen in the First Hospital of China Medical University were randomly divided into observation group and control group. The observation group was treated by hydrocolloid dressing placed on the skin above puncture point along with the blood vessels, control group was treated regularly, and the incidence of phlebitis in two groups was compared.

The incidence of phlebitis in the observation group was 10.5%, while the control group was 31.6% , with a statistically significant difference between the two groups (χ²=5.067, P<0.05).

Hydrocolloid dressing can effectively reduce phlebitis caused by Oxaliplatin and protect patient′s peripheral vein. It has the advantages of easily operation, comfortable feeling, and can also save unnecessary manpower.